MA28276A1 - Preparation effervescente d'une substance basique a action pharmaceutique - Google Patents

Preparation effervescente d'une substance basique a action pharmaceutique

Info

Publication number
MA28276A1
MA28276A1 MA29140A MA29140A MA28276A1 MA 28276 A1 MA28276 A1 MA 28276A1 MA 29140 A MA29140 A MA 29140A MA 29140 A MA29140 A MA 29140A MA 28276 A1 MA28276 A1 MA 28276A1
Authority
MA
Morocco
Prior art keywords
basic substance
pharmaceutical action
effervescent preparation
effervescent
preparation
Prior art date
Application number
MA29140A
Other languages
English (en)
French (fr)
Inventor
Wolfgang Wiehl
Irene Loose
Ralf Buellesbach
Dieter Rehn
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MA28276A1 publication Critical patent/MA28276A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
MA29140A 2003-12-19 2006-06-26 Preparation effervescente d'une substance basique a action pharmaceutique MA28276A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz

Publications (1)

Publication Number Publication Date
MA28276A1 true MA28276A1 (fr) 2006-11-01

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29140A MA28276A1 (fr) 2003-12-19 2006-06-26 Preparation effervescente d'une substance basique a action pharmaceutique

Country Status (16)

Country Link
EP (1) EP1696874A1 (es)
JP (1) JP2007515418A (es)
KR (1) KR20060109492A (es)
CN (1) CN1893920A (es)
AR (1) AR046955A1 (es)
AU (1) AU2004308590A1 (es)
BR (1) BRPI0417796A (es)
CA (1) CA2550342A1 (es)
DE (1) DE10359790A1 (es)
EC (1) ECSP066649A (es)
IL (1) IL176356A0 (es)
MA (1) MA28276A1 (es)
MX (1) MXPA06006658A (es)
NO (1) NO20063327L (es)
WO (1) WO2005063199A1 (es)
ZA (1) ZA200604946B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CN102264358A (zh) * 2008-11-11 2011-11-30 博科药物化学有限公司 包含布洛芬、伪麻黄碱和扑尔敏的药物组合物
CN102438598B (zh) * 2009-05-27 2015-06-10 株式会社茶山医化 含有泡腾层的多层片
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN107951034B (zh) * 2017-12-01 2021-03-23 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Also Published As

Publication number Publication date
AR046955A1 (es) 2006-01-04
EP1696874A1 (de) 2006-09-06
KR20060109492A (ko) 2006-10-20
DE10359790A1 (de) 2005-07-21
CA2550342A1 (en) 2005-07-14
WO2005063199A1 (de) 2005-07-14
ZA200604946B (en) 2007-09-26
MXPA06006658A (es) 2006-08-31
AU2004308590A1 (en) 2005-07-14
ECSP066649A (es) 2006-10-25
BRPI0417796A (pt) 2007-03-20
CN1893920A (zh) 2007-01-10
JP2007515418A (ja) 2007-06-14
NO20063327L (no) 2006-07-18
IL176356A0 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
MY138289A (en) Pharmaceutical compositions
MA28276A1 (fr) Preparation effervescente d'une substance basique a action pharmaceutique
MA29378B1 (fr) Composition pharmaceutique comprenant une diphenyluree substituee par un omega-carboxyaryle pour le traitement du cancer
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
MA27347A1 (fr) Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
SE0001899D0 (sv) New compounds
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN07476A1 (fr) Derives de n-(pyridine -2- yl) - sulfonamide
MA28038A1 (fr) Thienopyrazoles
MA27443A1 (fr) Oxazoles et thiazoles nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf)
MA29693B1 (fr) Derives de xanthine en tant qu'agonistes hm74a selectifs
BR0007820A (pt) Formulações agonistas de exendina e métodos deadministração das mesmas
MA34655B1 (fr) Dérivés de 2,3- dihydroimidazo[1,2-c]quinazoléine substitués par un aminoalcool utiles pour traiter des troubles hyperprolifératifs et des maladies associées à l'angiogenèse
MA27937A1 (fr) Dérivés d'indazole 3, 5-disubstitués, compositions pharmaceutiques, et méthodes de médiation ou d'inhibition de la prolifération cellulaire
MA30041B1 (fr) Immunoglobulines
MA27661A1 (fr) Indolone-oxazolidinones antibacteriennes, intermediaires pour leur preparation et compositions pharmaceutiques les contenant
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
BR9810520A (pt) Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TNSN00139A1 (fr) Acides phenoxyacetiques substitues
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
TNSN01052A1 (fr) Metabolites du (-) - cis - 6 - phenyl - 5 - [4 -( 2-pyrrolidine -1- yl - ethoxy) - phenyl] - 5,6,7,8- tetrahydro - naphtalene - 2 - ol et compositions les contenant